While there are no reports of loss-of-function mutations of the APache gene in AD patients, its transcription was significantly reduced in frontotemporal lobar degeneration associated with the MAPT p.R406W mutation and supranuclear palsy [50]. The gene discussed is MAPT; the disease is Alzheimer disease.